NCT00643929 - LENS - Long-term Eltrombopag Observational Study | Biotech Hunter

Enrollment

164

Participants

Timeline

Start Date

February 28, 2007

Primary Completion Date

March 31, 2013

Study Completion Date

March 31, 2013

Conditions

Purpura, Thrombocytopaenic, Idiopathic

Interventions

DRUG

Eltrombopag

Subjects participated in a prior eltrombopag study, having received either eltrombopag or placebo

Trial Locations (71)

1008

GSK Investigational Site, Montfleury

GSK Investigational Site, Tunis

1529

GSK Investigational Site, Budapest

1756

GSK Investigational Site, Sofia

2217

GSK Investigational Site, Kogarah

3029

GSK Investigational Site, Sfax

4000

GSK Investigational Site, Plovdiv

GSK Investigational Site, Sousse

13285

GSK Investigational Site, Marseille

13353

GSK Investigational Site, Berlin

14033

GSK Investigational Site, Caen

15706

GSK Investigational Site, Santiago de Compostela

16132

GSK Investigational Site, Genoa

20007

GSK Investigational Site, Washington D.C.

20014

GSK Investigational Site, San Sebastián

20132

GSK Investigational Site, Milan

20157

GSK Investigational Site, Milan

21021

GSK Investigational Site, Vinnytsia

23249

GSK Investigational Site, Richmond

25123

GSK Investigational Site, Brescia

27710

GSK Investigational Site, Durham

28006

GSK Investigational Site, Madrid

28034

GSK Investigational Site, Madrid

33604

GSK Investigational Site, Pessac

38320

GSK Investigational Site, Santa Cruz de Tenerife

41014

GSK Investigational Site, Seville

48202

GSK Investigational Site, Detroit

49102

GSK Investigational Site, Dnipropetrovsk

54511

GSK Investigational Site, Vandœuvre-lès-Nancy

71013

GSK Investigational Site, San Giovanni Rotondo

75300

GSK Investigational Site, Karachi

75571

GSK Investigational Site, Paris

76031

GSK Investigational Site, Rouen

83100

GSK Investigational Site, Avellino

83114

GSK Investigational Site, Donetsk

85724

GSK Investigational Site, Tucson

92118

GSK Investigational Site, Clichy

117997

GSK Investigational Site, Moscow

125167

GSK Investigational Site, Moscow

191024

GSK Investigational Site, St'Petersburg

191167

GSK Investigational Site, Saint Petersburg

197758

GSK Investigational Site, Saint Petersburg

198255

GSK Investigational Site, Saint Petersburg

400036

GSK Investigational Site, Mumbai

443011

GSK Investigational Site, Samara

600010

GSK Investigational Site, Chennai

T2N 4Z6

GSK Investigational Site, Calgary

V8V 3P9

GSK Investigational Site, Victoria

R3E 3P4

GSK Investigational Site, Winnipeg

B3H 2Y9

GSK Investigational Site, Halifax

H2X 3J4

GSK Investigational Site, Montreal

656 53

GSK Investigational Site, Brno

140 21

GSK Investigational Site, Prague

180 81

GSK Investigational Site, Prague

Unknown

GSK Investigational Site, Shatin, New Territories

GSK Investigational Site, Bangalore

700 054

GSK Investigational Site, Kolkata

00133

GSK Investigational Site, Rome

Lima 41

GSK Investigational Site, Lima

Lima 27

GSK Investigational Site, Lima

61-866

GSK Investigational Site, Poznan

00909

GSK Investigational Site, San Juan

105 229

GSK Investigational Site, Moscow

08907

GSK Investigational Site, Barcelona

SE-141 86

GSK Investigational Site, Stockholm

SE-171 76

GSK Investigational Site, Stockholm

01030

GSK Investigational Site, Kyiv

PL6 8DH

GSK Investigational Site, Plymouth

G12 0YN

GSK Investigational Site, Glasgow

NW1 2BU

GSK Investigational Site, London

SA6 6NL

GSK Investigational Site, Morriston